Shibahara H, Mitsuo M, Inoue M, Hasegawa A, Shigeta M, Koyama K
Department of Obstetrics and Gynecology, Hyogo College of Medicine, Nishinomiya, Japan.
Hum Reprod. 1998 Jul;13(7):1928-32. doi: 10.1093/humrep/13.7.1928.
The zona-free hamster egg penetration test (HEPT) is widely used for evaluating the fertilizing ability of human spermatozoa. However, the relationship between the HEPT and microassisted fertilization has yet to be determined. To evaluate the efficiency of HEPT in selecting the most appropriate method of in-vitro fertilization (IVF), including intracytoplasmic sperm injection (ICSI) in couples with male factor infertility, clinical laboratory data was analysed retrospectively. The patients were divided into groups according to the sperm penetration index as determined by the HEPT: group A (sperm penetration index = 0), group B (sperm penetration index < 15) and group C (sperm penetration index > or = 15). A total of 405 oocytes were collected and inseminated by conventional methods in 69 couples with male factor infertility. In all, 31 out of 148 (20.9%) oocytes fertilized in group A; 35 out of 117 (29.9%) in group B; and 73 of 140 (52.1%) in group C. The clinical pregnancy rates per transfer in groups A, B and C were 0% (0/13), 0% (0/14) and 25.9% (7/27) respectively. Both the fertilization rate and pregnancy rate in group C was significantly higher than in groups A and B. ICSI was carried out in a total of 57 couples and 334 oocytes in metaphase II stage were manipulated. The normal fertilization (2 pronuclear) rate per oocyte was 65.6 +/- 26.0% (mean +/- SD). Out of 127 oocytes, 76 (59.8%) fertilized in group A, 57 out of 87 oocytes (65.5%) in group B and 86 out of 120 oocytes (71.7%) in group C. Of the 56 transfers, 17 clinical pregnancies were obtained, giving an average pregnancy rate of 30.4% per transfer. The clinical pregnancy rates per transfer in groups A, B and C were 17.4% (4/23), 40.0% (4/10) and 39.1% (9/23) respectively. No significant differences were observed in the fertilization rates or in the pregnancy rates between the three groups. In addition, there were no differences in the fertilization and pregnancy rates between the ICSI and IVF patients in group C. These findings suggest that the results of the HEPT are well correlated with the fertilizing ability of human spermatozoa in the patients treated by conventional IVF. Couples suffering from male factor infertility with a sperm penetration index of < 15 (as determined by HEPT) should consider treatment with ICSI, while those with a sperm penetration index of > or = 15 should attempt conventional IVF.
无透明带仓鼠卵穿透试验(HEPT)被广泛用于评估人类精子的受精能力。然而,HEPT与微辅助受精之间的关系尚未确定。为了评估HEPT在选择最合适的体外受精(IVF)方法(包括对男性因素不育夫妇进行卵胞浆内单精子注射(ICSI))中的效率,对临床实验室数据进行了回顾性分析。根据HEPT确定的精子穿透指数将患者分为几组:A组(精子穿透指数 = 0)、B组(精子穿透指数 < 15)和C组(精子穿透指数≥15)。共收集了405个卵母细胞,并通过常规方法对69对男性因素不育夫妇进行授精。总体而言,A组148个卵母细胞中有31个(20.9%)受精;B组117个卵母细胞中有35个(29.9%)受精;C组140个卵母细胞中有73个(52.1%)受精。A、B、C三组每次移植的临床妊娠率分别为0%(0/13)、0%(0/14)和25.9%(7/27)。C组的受精率和妊娠率均显著高于A组和B组。共对57对夫妇进行了ICSI,对334个处于中期II期的卵母细胞进行了操作。每个卵母细胞的正常受精(2原核)率为65.6±26.0%(平均值±标准差)。在127个卵母细胞中,A组76个(59.8%)受精,B组87个卵母细胞中有57个(65.5%)受精,C组120个卵母细胞中有86个(71.7%)受精。在56次移植中,获得了17例临床妊娠,每次移植的平均妊娠率为30.4%。A、B、C三组每次移植的临床妊娠率分别为17.4%(4/23)、40.0%(4/10)和39.1%(9/23)。三组之间在受精率或妊娠率方面未观察到显著差异。此外,C组中ICSI患者和IVF患者的受精率和妊娠率也没有差异。这些发现表明,HEPT的结果与接受常规IVF治疗患者的人类精子受精能力密切相关。精子穿透指数<15(由HEPT确定)的男性因素不育夫妇应考虑ICSI治疗,而精子穿透指数≥15的夫妇应尝试常规IVF。